investment

R&D

London’s life sciences scene upbeat as 2024 conference seaso...

With 2024 well under way, influential conferences in London have given a barometer reading on the conditions in the European biopharma market, reports Richard Staines.

R&D

Green shoots and cautious optimism: Insights from BIO-Europe...

With thousands of pharma and biotech dealmakers attending last months’ BIO-Europe Spring, appetite for partnering looked alive and well.

Oncology

Why is pharma going gaga for radiopharmaceuticals?

The pharma industry is always on the lookout for new therapeutic angles that might prove to be a competitive advantage.

Sales & Marketing

Securing top talent in a dynamic healthcare market

The pharma talent market can be a tricky thing to navigate.

Patients

Women’s health is a priority not a charity

Women make up half of our planet’s population.

Market Access

Too many UK life sciences companies tolerate commercial fail...

A trip to the annual Medica trade fair in Dusseldorf is a must for people like me, looking to keep on top of what’s happening globally in the field of biotech, medical technology, and pharm